Metabolomics Market Report: Trends, Forecast and Competitive Analysis
In Progress. Get it in 2 to 4 weeks by ordering today
The future of the global metabolomics market looks promising with opportunities in various appliations, such as biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and personalized medicine. The global metabolomics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing research and development activities in pharmaceutical and biotechnology and increasing prevalence of chronic diseases.
Emerging trends, which have a direct impact on the dynamics of the industry, include growing adoption of HPLC and UPLC technique for its most versatile separation method.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global metabolomics market report, please download the report brochure.
metabolomics
In this market, metabolomics instruments is the largest product and service of metabolomics, whereas biomarker discovery is the largest application. Growth in various segments of the metabolomics market are given below:
metabolomics
The study includes trends and forecast for the global metabolomics market by product and service, application, indication, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Metabolomics InstrumentsSeparation ToolsDetection Tools Metabolomics Bioinformatics Tools and Services
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biomarker DiscoveryDrug DiscoveryToxicology TestingNutrigenomicsFunctional GenomicsPersonalized MedicineOther Applications
By Indication [Value ($ Million) shipment analysis for 2014 – 2025]:
CancerCardiovascular DisordersNeurological DisordersInborn Errors of MetabolismOther Indications
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the metabolomics companies profiled in this report include Agilent Technologies, Bio- Rad Laboratories, Bruker Corporation, Danaher, Thermo Fisher Scientific, Waters Corporation, Shimadzu Corporation, LECO Corporation, Biocrates Life Sciences, and Metabolon.
Lucintel forecasts that metabolomics instruments will remain the largest product and service segment over the forecast period, as they are mostly used in research activities.
Within this market, biomarker discovery will remain the largest application segment over the forecast period due to rising prevalance of chronic diseases, such as cancer and diabetes, and increasing acceptance of cancer diagnostic tests.
North America will remain the largest region over the forecast period due to high per capita healthcare expenditure and increasing adoption of healthcare technology.
Features of the Global Metabolomics Market
Market Size Estimates: Global metabolomics market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global metabolomics market size by various segments, such as product and service, application, and indication in terms of value.Regional Analysis: Global metabolomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product and service, application, indication, and region for the global metabolomics market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global metabolomics market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global metabolomics market by product and service (metabolomics instruments, separation tools and detection tools ) and metabolomics bioinformatics tools and services), application (biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications), indication (cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other indications), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global metabolomics market?
Q.5 What are the business risks and threats to the global metabolomics market?
Q.6 What are the emerging trends in this metabolomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this metabolomics market?
Q.8 What are the new developments in this metabolomics market? Which companies are leading these developments?
Q.9 Who are the major players in this metabolomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this metabolomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global metabolomics market?
The future of the global metabolomics market looks promising with opportunities in various appliations, such as biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, and personalized medicine. The global metabolomics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing research and development activities in pharmaceutical and biotechnology and increasing prevalence of chronic diseases.
Emerging trends, which have a direct impact on the dynamics of the industry, include growing adoption of HPLC and UPLC technique for its most versatile separation method.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global metabolomics market report, please download the report brochure.
metabolomics
In this market, metabolomics instruments is the largest product and service of metabolomics, whereas biomarker discovery is the largest application. Growth in various segments of the metabolomics market are given below:
metabolomics
The study includes trends and forecast for the global metabolomics market by product and service, application, indication, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Metabolomics InstrumentsSeparation ToolsDetection Tools Metabolomics Bioinformatics Tools and Services
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Biomarker DiscoveryDrug DiscoveryToxicology TestingNutrigenomicsFunctional GenomicsPersonalized MedicineOther Applications
By Indication [Value ($ Million) shipment analysis for 2014 – 2025]:
CancerCardiovascular DisordersNeurological DisordersInborn Errors of MetabolismOther Indications
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the metabolomics companies profiled in this report include Agilent Technologies, Bio- Rad Laboratories, Bruker Corporation, Danaher, Thermo Fisher Scientific, Waters Corporation, Shimadzu Corporation, LECO Corporation, Biocrates Life Sciences, and Metabolon.
Lucintel forecasts that metabolomics instruments will remain the largest product and service segment over the forecast period, as they are mostly used in research activities.
Within this market, biomarker discovery will remain the largest application segment over the forecast period due to rising prevalance of chronic diseases, such as cancer and diabetes, and increasing acceptance of cancer diagnostic tests.
North America will remain the largest region over the forecast period due to high per capita healthcare expenditure and increasing adoption of healthcare technology.
Features of the Global Metabolomics Market
Market Size Estimates: Global metabolomics market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global metabolomics market size by various segments, such as product and service, application, and indication in terms of value.Regional Analysis: Global metabolomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product and service, application, indication, and region for the global metabolomics market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global metabolomics market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global metabolomics market by product and service (metabolomics instruments, separation tools and detection tools ) and metabolomics bioinformatics tools and services), application (biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications), indication (cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other indications), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global metabolomics market?
Q.5 What are the business risks and threats to the global metabolomics market?
Q.6 What are the emerging trends in this metabolomics market and the reasons behind them?
Q.7 What are some changing demands of customers in this metabolomics market?
Q.8 What are the new developments in this metabolomics market? Which companies are leading these developments?
Q.9 Who are the major players in this metabolomics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this metabolomics market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global metabolomics market?
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Metabolomics Market Trends and Forecast
3.3: Global Metabolomics Market by Product and Service
3.3.1: Metabolomics Instruments
3.3.1.1: Separation Tools
3.3.1.2: Detection Tools
3.3.2: Metabolomics Bioinformatics Tools and Services
3.4: Global Metabolomics Market by Application
3.4.1: Biomarker Discovery
3.4.2: Drug Discovery
3.4.3: Toxicology Testing
3.4.4: Nutrigenomics
3.4.5: Functional Genomics
3.4.6: Personalized Medicine
3.4.7: Other Applications
3.5: Global Metabolomics Market by Indication
3.5.1: Cancer
3.5.2: Cardiovascular Disorders
3.5.3: Neurological Disorders
3.5.4: Inborn Errors of Metabolism
3.5.5: Other Indications
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Metabolomics Market by Region
4.2: North American Metabolomics Market
4.2.1: Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.2.2: Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.2.3: Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.2.4: The United States Metabolomics Market
4.2.5: The Canadian Metabolomics Market
4.2.6: The Mexican Metabolomics Market
4.3: European Metabolomics Market
4.3.1: Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.3.2: Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.3.3: Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.3.4: The Metabolomics Market of United Kingdom
4.3.5: The Spanish Metabolomics Market
4.3.6: The German Metabolomics Market
4.3.7: The French Metabolomics Market
4.4: APAC Metabolomics Market
4.4.1: Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.4.2: Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.4.3: Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.4.4: The Chinese Metabolomics Market
4.4.5: The Indian Metabolomics Market
4.4.6: The Japanese Metabolomics Market
4.5: ROW Metabolomics Market
4.5.1: Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.5.2: Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.5.3: Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.5.4: Brazilian Metabolomics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Metabolomics Market by Product and Service
7.1.2: Growth Opportunities for the Global Metabolomics Market by Application
7.1.3: Growth Opportunities for the Global Metabolomics Market by Indication
7.1.4: Growth Opportunities for the Global Metabolomics Market by Region
7.2: Emerging Trends in the Global Metabolomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Metabolomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Metabolomics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Agilent Technologies, Inc.
8.2: Bio- Rad Laboratories, Inc.
8.3: Bruker Corporation
8.4: Danaher Corporation
8.5: Therm Fisher Scientific, Inc.
8.6: Waters Corporation
8.7: Shimadzu Corporation
8.8: LECO Corporation
8.9: Biocrates Life Sciences AG
8.10: Metabolon, Inc.
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Metabolomics Market Trends and Forecast
3.3: Global Metabolomics Market by Product and Service
3.3.1: Metabolomics Instruments
3.3.1.1: Separation Tools
3.3.1.2: Detection Tools
3.3.2: Metabolomics Bioinformatics Tools and Services
3.4: Global Metabolomics Market by Application
3.4.1: Biomarker Discovery
3.4.2: Drug Discovery
3.4.3: Toxicology Testing
3.4.4: Nutrigenomics
3.4.5: Functional Genomics
3.4.6: Personalized Medicine
3.4.7: Other Applications
3.5: Global Metabolomics Market by Indication
3.5.1: Cancer
3.5.2: Cardiovascular Disorders
3.5.3: Neurological Disorders
3.5.4: Inborn Errors of Metabolism
3.5.5: Other Indications
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Metabolomics Market by Region
4.2: North American Metabolomics Market
4.2.1: Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.2.2: Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.2.3: Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.2.4: The United States Metabolomics Market
4.2.5: The Canadian Metabolomics Market
4.2.6: The Mexican Metabolomics Market
4.3: European Metabolomics Market
4.3.1: Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.3.2: Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.3.3: Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.3.4: The Metabolomics Market of United Kingdom
4.3.5: The Spanish Metabolomics Market
4.3.6: The German Metabolomics Market
4.3.7: The French Metabolomics Market
4.4: APAC Metabolomics Market
4.4.1: Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.4.2: Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.4.3: Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.4.4: The Chinese Metabolomics Market
4.4.5: The Indian Metabolomics Market
4.4.6: The Japanese Metabolomics Market
4.5: ROW Metabolomics Market
4.5.1: Market by Product and Service: Metabolomics Instruments (Separation Tools and Detection Tools) and Metabolomics Bioinformatics Tools and Services
4.5.2: Market by Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Other Applications
4.5.3: Market by Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Other Indications
4.5.4: Brazilian Metabolomics Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Metabolomics Market by Product and Service
7.1.2: Growth Opportunities for the Global Metabolomics Market by Application
7.1.3: Growth Opportunities for the Global Metabolomics Market by Indication
7.1.4: Growth Opportunities for the Global Metabolomics Market by Region
7.2: Emerging Trends in the Global Metabolomics Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Metabolomics Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Metabolomics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Agilent Technologies, Inc.
8.2: Bio- Rad Laboratories, Inc.
8.3: Bruker Corporation
8.4: Danaher Corporation
8.5: Therm Fisher Scientific, Inc.
8.6: Waters Corporation
8.7: Shimadzu Corporation
8.8: LECO Corporation
8.9: Biocrates Life Sciences AG
8.10: Metabolon, Inc.
